List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 38 studies with search of: Open Studies | "Duodenal Neoplasms"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Pancreatitis, Chronic;   Duodenal Neoplasms
Intervention: Procedure: pancreaticojejunostomy
2 Recruiting Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
Conditions: Familial Adenomatous Polyposis;   Duodenal Neoplasms;   Duodenal Polyps
Interventions: Drug: Celecoxib;   Drug: Ursodeoxycholic acid;   Drug: Placebo
3 Recruiting Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-Resectable Periampullary Cancer
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Duodenal Neoplasms
Interventions: Procedure: surgery;   Procedure: endoscopic strategy
4 Recruiting Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Bile Duct Neoplasms;   Ampullary Neoplasms;   Duodenal Neoplasms;   Pancreatitis
Interventions: Procedure: Billroth-II-type reconstruction;   Procedure: Isolated Roux-en-Y type reconstruction
5 Recruiting Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer;   Pancreatic Cancer;   Periampullary Adenocarcinoma;   Small Intestine Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin;   Other: laboratory biomarker analysis
6 Recruiting Batracylin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: daniquidone;   Other: pharmacological study
7 Recruiting Vaccine Therapy in Treating Patients Who Have Undergone Autologous Stem Cell Transplant for High-Risk Lymphoma or Multiple Myeloma
Conditions: Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Small Intestine Cancer
Interventions: Biological: pneumococcal polyvalent vaccine;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
8 Recruiting Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
Conditions: Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: pharmacological study
9 Recruiting High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: methotrexate;   Drug: prednisolone;   Drug: vincristine sulfate;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: biopsy;   Procedure: peripheral blood stem cell transplantation
10 Recruiting Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment
Conditions: Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer
Interventions: Drug: everolimus;   Other: laboratory biomarker analysis
11 Recruiting Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Drug: vorinostat;   Genetic: DNA analysis;   Other: immunohistochemistry staining method;   Other: immunologic technique;   Other: laboratory biomarker analysis
12 Recruiting Pazopanib in Treating Patients With Metastatic Soft Tissue Sarcoma That Has Relapsed or Not Responded to Treatment
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Peripheral Nervous System Neoplasm;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: pazopanib hydrochloride;   Other: placebo
13 Recruiting Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer
Interventions: Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: indium In 111-labeled autologous peripheral blood mononuclear cells;   Radiation: indium In 111-labeled autologous polymorphonuclear leukocytes
14 Recruiting Pazopanib in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
Conditions: Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride;   Other: pharmacological study
15 Recruiting Rituximab in Treating Patients Undergoing Stem Cell Transplant for B-Cell Cancer That Has Relapsed or Not Responded to Treatment
Conditions: Graft Versus Host Disease;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Precancerous Condition;   Small Intestine Cancer
Interventions: Biological: rituximab;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: pharmacological study
16 Recruiting Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: cediranib maleate;   Genetic: TdT-mediated dUTP nick end labeling assay;   Other: flow cytometry;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
17 Recruiting Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Conditions: Non-Melanomatous Skin Cancer;   Pancreatic Cancer;   Small Intestine Cancer;   Testicular Germ Cell Tumor
Interventions: Genetic: in situ hybridization;   Genetic: protein expression analysis;   Other: immunologic technique
18 Recruiting 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: gemcitabine hydrochloride;   Drug: triapine
19 Recruiting Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders;   Graft Versus Host Disease;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Secondary Myelofibrosis;   Small Intestine Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiation
20 Recruiting Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer
Condition: Small Intestine Cancer
Interventions: Drug: capecitabine;   Drug: irinotecan hydrochloride;   Drug: oxaliplatin

Previous Page Studies Shown (1-20) Next Page (21-38)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services